Amanote Research
Register
Sign In
Influence of Severity of Illness on the Effects of Eritoran Tetrasodium (E5564), a TLR4 Antagonist, in Patients With Severe Sepsis
Critical Care
- United Kingdom
doi 10.1186/cc8062
Full Text
Open PDF
Abstract
Available in
full text
Categories
Critical Care
Intensive Care Medicine
Date
January 1, 2009
Authors
SM Opal
AC Kalil
SP LaRosa
J Gogate
M Lynn
AE Wittek
Publisher
Springer Science and Business Media LLC
Related search
Toll-Like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury Through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Impact of Blood Glucose Abnormalities on Outcomes and Disease Severity in Patients With Severe Sepsis: An Analysis From a Multicenter, Prospective Survey of Severe Sepsis
PLoS ONE
Multidisciplinary
Influence of Severity of Illness on Neutrophil Gelatinase-Associated Lipocalin Performance as a Marker of Acute Kidney Injury: A Prospective Cohort Study of Patients With Sepsis
BMC Nephrology
Nephrology
The Effects of Steroids During Sepsis Depend on Dose and Severity of Illness: An Updated Meta-Analysis
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Using of TLR2 and TLR4 as Biomarker of Sepsis Severity Detection
Al-Mustansiriyah Journal of Science
Hyperuricemia: An Early Marker for Severity of Illness in Sepsis
International Journal of Nephrology
Nephrology
Eritoran: The Evidence of Its Therapeutic Potential in Sepsis
Core Evidence
Medicine
Reviews
References
Pharmacology
The Effects of Motivation Feedback in Patients With Severe Mental Illness: A Cluster Randomized Controlled Trial
Neuropsychiatric Disease and Treatment
Outcomes of Neutropenic Patients With Severe Sepsis on a Specialist Cancer ICU
Critical Care
Critical Care
Intensive Care Medicine
